Pharmacokinetics of Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Glimepiride Following Co-administration in Healthy Volunteers: A Randomised, Open-label, Crossover Study

Macha, S., Mattheus, M., Pinnetti, S., Seman, L., & Woerle, H. J. (2012). Pharmacokinetics of Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Glimepiride Following Co-administration in Healthy Volunteers: A Randomised, Open-label, Crossover Study. Journal of Diabetes Research and Clinical Metabolism, 1(1), 14. https://doi.org/10.7243/2050-0866-1-14